Then we investigated E2F2 expression in CRC based on TCGA and GEO databases and our clinical specimens, which illustrated that E2F2 expression was significantly downregulated in the CRC tissues at both mRNA and protein levels, compared with normal tissues. Here, E2F2 is linked to colorectal carcinoma.